is year has seen new initiatives to raise money to fund HIV prevention and care services, including antiretrovirals and the infrastructure to deliver them, in the developing world. At the World Economic Forum in Davos in January, the pop-music celebrity Bono announced the "Product Red" brand to fight HIV/AIDS in AfricaNew philanthropic and taxation efforts to fight HIV/AIDS must be encouraged. The cynical view that businesses are simply getting free good publicity and an increased feel-good factor, and will pass higher charges onto consumers, must be challenged. We support these new initiatives and encourage other businesses to join Product Red."

'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
9-Mar-2006

Page: 1 2
Related medicine news :

1. Study shows interruption of antiretroviral therapy increases risk of disease and death
2. No advantage for four-drug antiretroviral regimen vs. three-drug for initial treatment of HIV-1
3. Sub-Saharan Africans with HIV may achieve favorable levels of antiretroviral therapy adherence
4. Saving antiretroviral treatment in long-term HIV-positive patients
5. Access to antiretrovirals unlikely to reduce HIV infection rates
6. Study sets new gold standard for initial antiretroviral treatment of HIV infection
7. International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy
8. HIV mortality in India drops with introduction of generic antiretroviral therapy
9. Highly active antiretrovirals for HIV can substantially reduce rates of AIDS
10. Chemotherapy with bevacizumab increases risk of blood clots in arteries
11. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone